Bin Zou
Founder & Chief Executive Officer Axcynsis
Seminars
Tuesday 9th June 2026
Analyzing the Benefits of Using Cysteine Conjugation vs. Other Conjugation Technologies on Bispecific ADCs & Their Success Rate in Improving Stability of the Molecule
2:15 pm
- Evaluating cysteine conjugation vs. lysine, enzymatic and site-specific technologies, and their effect on DAR ratio and uniformity
- Assessing the impact of each conjugation technology on ADC stability
- Exploring how each conjugation technology affects clinical performance
